PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2010; 5(10): e13109.
Published online 2010 October 1. doi:  10.1371/journal.pone.0013109
PMCID: PMC2948507

Failure of Effector Function of Human CD8+ T Cells in NOD/SCID/JAK3−/− Immunodeficient Mice Transplanted with Human CD34+ Hematopoietic Stem Cells

Derya Unutmaz, Editor

Abstract

Humanized mice, which are generated by transplanting human CD34+ hematopoietic stem cells into immunodeficient mice, are expected to be useful for the research on human immune responses. It is reported that antigen-specific T cell responses occur in immunodeficient mice transplanted with both human fetal thymus/liver tissues and CD34+ fetal cells, but it remains unclear whether antigen-specific T cell responses occur in those transplanted with only human CD34+ hematopoietic stem cells (HSCs). Here we investigated the differentiation and function of human CD8+ T cells reconstituted in NOD/SCID/Jak3−/− mice transplanted with human CD34+ HSCs (hNOK mice). Multicolor flow cytometric analysis demonstrated that human CD8+ T cells generated from the CD34+ HSCs comprised only 3 subtypes, i.e., CD27highCD28+CD45RA+CCR7+, CD27+CD28+CD45RACCR7+, and CD27+CD28+CD45RACCR7 and had 3 phenotypes for 3 lytic molecules, i.e., perforin(Per)granzymeA(GraA)granzymeB(GraB), PerGraA+GraB, and PerlowGraA+GraB+. These CD8+ T cells failed to produce IFN-γ and to proliferate after stimulation with alloantigens. These results indicate that the antigen-specific T cell response cannot be elicited in mice transplanted with only human CD34+ HSCs, because the T cells fail to develop normally in such mice.

Introduction

Humanized mice are generated by transplanting human CD34+ hematopoietic stem cells (HSCs) into immunodeficient mice and are expected to become a useful tool in studies on human T cell immune responses, infectious diseases, preclinical testing of vaccines, and new therapeutic strategies. Previous studies showed long-term human T cell and B cell reconstitution in NOD/SCID/γcnull immunodeficient mice transplanted with human CD34+ HSCs (hNOG mice) [1][3]. Human IgM, IgG, and IgA were detectable in the serum of these mice; and class-switching of immunoglobulin in human cord blood (CB)-derived B cells properly occurred in the mice [4][7], indicating that the human B cells can develop from human CD34+ HSCs in the hNOG mice and are functionally competent to produce immunoglobulins in them. Furthermore, previous studies demonstrated that human CD4/CD8 double-positive and human CD4/CD8 single positive T cells were observed in the thymus of the hNOG mice and that the latter were found in the spleen and peripheral blood of these animals [3][5], [7], [8]. These human T cells expressed predominantly αβ T cell receptors in the thymus and the spleen of the recipient, whereas CD45RA+ naive T cells were identified in the spleen and the peripheral blood of the hNOG mice [4], [9], [10]. These results suggest the possibility that the human T cells respond to highly diverse molecules. Additionally, proliferation and IFN-γ expression of EBV-specific human CD8+ T cells have been demonstrated in hNOG mice and in Rag2−/−γc−/− mice transplanted with human CD34+ HSCs after an EBV infection [8], [11]. In contrast, high-dose injection of EBV caused a fatal lymphoproliferative disorder in the hNOG mice, whereas lower-dose injection induces an apparently asymptomatic persistent infection [11]. These findings suggest that the human T cell responses were not able to control the replication of EBV in the hNOG mice.

On the other hand, antigen-specific T cell immune responses had definitely been shown in humanized NOD/SCID mice established by transplanting human fetal thymus/liver tissues and CD34+ fetal liver cells into them (BLT mice) [12][16]. However, there are no studies providing reliable evidence as to whether or not antigen-specific T cell responses are induced in humanized mice established by transplanting only human CD34+ HSCs into immunodeficient mice.

The phenotypic analysis of human T cells in humanized mice is useful to clarify their differentiation and effector function, because the phenotypic classification of human T cells reflects their differentiation and effector function. Previous studies demonstrated that human CD8+ T cells change the expression levels of co-stimulatory molecules (CD27, CD28, and CD45RA) [17][19] and chemokine receptor CCR7 on their surface according to their differentiation and maturation [20], [21]. The phenotypic analysis of human CD8+ T cells showed that CD27highCD28+CD45RA+CCR7+, CD27+CD28+CD45RACCR7+, CD27+CD28+CD45RACCR7, CD27lowCD28CD45RA+/−CCR7, and CD27CD28CD45RA+/−CCR7 have characteristics of naive, central memory, early effector memory, late effector memory, and effector CD8+ T cells, respectively [22], [23]. Moreover, human CD8+ T cells express 3 key cytolytic effector molecules, i.e., perforin (Per), granzyme A (GraA), and granzyme B (GraB) in response to their differentiation [24]. Five subpopulations of human CD8+ T cells defined by these cytolytic molecules exist and appear sequentially during CD8+ T cell differentiation: PerGraAGraB, PerGraA+GraB, PerlowGraA+GraB, PerlowGraA+GraB+, and PerhighGraA+GraB+ [25]. Thus, the functional subsets of human CD8+ T cells can be identified by the phenotypic classification and the expression of these 3 cytolytic molecules [25]. By using these classifications of human CD8+ T cells, the differentiation and function of human CD8+ T cells reconstituted in humanized mice can be clarified in detail. A previous study showed that the CD45RA+CCR7 subset were detected in hNOG mice [10], suggesting the possibility that human CD8+ T cells can be differentiated in the mice. However, since this study did not demonstrated the existence of effector subset, CD27CD28CD45RA+/−CCR7, it still remains unclear if human CD8+ T cells can be differentiated into effector cells in hNOG mice.

In the present study, to clarify antigen-specific human CD8+ T cell responses in immunodeficient mice transplanted with only human CD34+ HSCs, we established NOD/SCID/JAK3−/− (NOK) mice transplanted with human CD34+ HSCs (hNOK mice) and investigated the differentiation and function of human CD8+ T cells reconstituted in these mice. Especially, we focused on performing phenotypic classification based on the expression of the above-mentioned effector molecules and the alloreactivity of human CD8+ T cells reconstituted in the mice.

Results

Reconstitution of human T cells in hNOK mice

hNOK mice were established by transplanting human CD34+ HSCs isolated from human CB into the liver of newborn NOK mice. In order to investigate the reconstitution of the human immune system in these mice, we obtained PBMC from the mice at 10, 12 and 17 weeks after the transplantation and then analyzed them by using flow cytometry for detecting human T and B cells. As shown in Table 1, the cells expressing common human leukocyte antigen CD45 (hCD45+) were found in all hNOK mice at 10 weeks after the transplantation (n = 31). Among the hCD45+ cells, human B cells, identified by the expression of CD19, were observed in all hNOK mice, whereas human T cells, identified by the expression of CD3, were observed in approximately 60% of the mice (Table 1). In the mice carrying human T cells, the proportion of human T cells gradually increased from 10 to 17 weeks after the transplantation and reached a level at 17 weeks similar to the proportion of CD8+ T cells in the human adult PBMC population (Figure 1A and 1B). The human T cells obtained during the period of 10-17 weeks post transplantation included both human CD4+ and CD8+ T cells (Figure 1C), though the ratio of human CD4/CD8 T cells gradually increased from the 10 to 17 weeks (Figure 1D). These results show that human CD8+ and CD4+ T cells were generated and maintained in the mice.

Figure 1
Flow cytometric analysis of human T cells reconstituted in hNOK mice.
Table 1
Proportion of human immune cells in hNOK mice.

Phenotypic analysis of human T cells reconstituted in hNOK mice

Human peripheral CD8+ T cells are classified into the following 5 major populations based on their expression of 4 cell-surface markers: CD27highCD28+CD45RA+CCR7+ (naive subset), CD27+CD28+CD45RACCR7+ (central memory subset), CD27+CD28+CD45RACCR7 (early effector memory subset), CD27lowCD28CD45RA+/−CCR7 (late effector memory subset), and CD27CD28CD45RA+/−CCR7 (effector subset) [22], [23]; whereas human peripheral CD4+ T cells are also classified into 5 major populations by the same 4 cell-surface markers, i.e., CD27+CD28+CD45RA+CCR7+ (naive subset), CD27+CD28+CD45RACCR7+ (central memory subset), CD27+CD28+CD45RACCR7 (Th0 effector memory subset), CD27-CD28+CD45RACCR7 (Th1/2 effector memory subset), and CD27CD28CD45RACCR7 (effector subset) [26]. To examine the differentiation of human T cells reconstituted in the hNOK mice, we analyzed the phenotype of human T cells among PBMC from the mice at 17 weeks after the transplantation and that of T cells among PBMC from adult humans for comparison. Representative results for an individual hNOK mouse and an adult human are shown in Figure 2A; and a summary of the findings, in Figure 2B. The reconstituted human CD8+ T cell population included naive (39.7±26.9%), central memory (18.9±9.7%), and early effector memory (18.4±15.9%) subsets. Late effector memory (0.9±1.6%) and effector (0.8±2.6%) subsets were hardly detected in the mice. These results suggest that the human CD8+ T cells did not differentiate into late effector or effector human T cells in the mice.

Figure 2
Phenotypic classification of human CD8+ T cells reconstituted in hNOK mice.

The phenotypic analysis of the reconstituted human CD4+ T cell population in the PBMC from the mice revealed that it included naive (27.5±23.0%), central memory (31.2±10.1%), Th0 effector memory (28.1±18.8%), and Th1/2 effector memory (9.0±11.4%) subsets. The effector (0.06±0.15%) subset was hardly detected, suggesting that the human CD4+ T cells did not differentiate into effector T cells in these mice.

Expression of 3 cytolytic effector molecules in reconstituted human CD8+ T cells

Human peripheral CD8+ T cells are classified into the following 5 major populations based on their expression levels of 3 effector molecules: PerGraAGraB, PerGraA+GraB, PerlowGraA+GraB, PerlowGraA+GraB+, and PerhighGraA+GraB+ [25]. To investigate the effector function of the human CD8+ T cells reconstituted in the hNOK mice, we examined the expression of these effector molecules in human CD8+ T cells among splenocytes from the mice. A representative result and summary of the analysis for 6 hNOK mice as well as for PBMC from 3 adult humans are shown in Figure 3A and 3B, respectively. The human CD8+ T cells included PerGraAGraB, PerGraA+GraB, and PerlowGraA+GraB+ cells. But they did not include PerlowGraA+GraB or PerhighGraA+GraB+ ones, though the latter were found among human adult PBMC. These results indicate that the reconstituted human CD8+ T cells did not have effector function in the mice and that the human CD8+ T cells did not differentiate into effector cells in the mice.

Figure 3
Expression of 3 cytolytic effector molecules of human CD8+ T cells reconstituted in hNOK mice.

Ability of reconstituted human CD8+ T cells to produce cytokines

Human CD8+ T cells producing IL-2 but not IFN-γ are mainly found in naive and central memory CD8+ T cell populations, whereas IFN-γ and TNF-α are mainly produced by effector memory and effector CD8+ T cells among human PBMC [22], [27]. To investigate the ability of the human CD8+ T cells reconstituted in the hNOK mice to produce these cytokines, we stimulated splenocytes isolated from these mice with PMA and ionomycin in vitro and measured the production of the above cytokines. A representative result and summary of the analysis for 12 hNOK mice are given in Figure 4A and 4B, respectively. The human CD8+ T cells reconstituted in the mice produced IFN-γ, TNF-α, and IL-2 (Figure 4A). The frequency of IFN-γ-producing CD8+ T cells positively correlated with that of the effector memory (CD27+CD28+CD45RACCR7 plus CD27lowCD28CD45RA+/−CCR7) subset, whereas the frequency of IL-2+IFN-γTNF-α-producing CD8+ T cells negatively correlated with that of effector memory subset (Figure 4B). These results indicate that the human CD8+ T cells had the ability to produce these cytokines in the mice.

Figure 4
Cytokine production of human CD8+ T cells reconstituted in hNOK mice.

Alloreactivity of human CD8+ T cells reconstituted in hNOK mice

It is well known that 0.1–10% of human T-cell repertoire react with alloantigens compared with a frequency of <1/100,000 for foreign antigens in humans [28], [29]. We investigated alloreactivity of human CD8+ T cells reconstituted in hNOK mice to clarify the responsiveness of antigen-specific human CD8+ T cells. We immunized hNOK mice with irradiated human PBMC from a healthy donor with HLA-A*2402/A*2402, B*5201/B*5901, and DRB1*1502/DRB1*0405 (allo-PBMC) (n = 4) and analyzed the phenotype of human CD8+ T cells reconstituted in the mice on 7 days or 31 days after the PBMC injection. Flow cytometric analysis demonstrated that CD27CD28CD45RA+/−CCR7 effector CD8+ T cell subsets and PerhighGraA+GraB+ cells were not induced in the mice on 7 days and 31 days after the PBMC injection (Figures S1A and S1B). We further analyzed the ability of the human CD8+ T cells to produce IFN-γ after allo-PBMC stimulation. The splenocytes from the mice obtained at 31 days after injection of the irradiated PBMC into the mice were cultured with the irradiated PBMC in vitro for 7 days, and then the ability of the human CD8+ T cells to produce IFN-γ was measured after stimulation with the irradiated PBMC. As shown in Figure 5A, the human CD8+ T cells and the CD8 T cells (mostly CD4+ T cells) reconstituted in the mice did not produce IFN-γ, suggesting that both CD8+ T cells and CD4+ T cells could not recognize alloantigen. In addition, we analyzed the ability of the human CD8+ T cells to proliferate after stimulation with alloantigens. The splenocytes of the mice on 31 days were labeled with CFSE (carboxyfluorescein diacetate N-succinimidyl ester); and the cells were cultured for 3 days with irradiated 721.221 cells expressing HLA-A*2402 (.221-A*2402) or irradiated 721.221 expressing HLA-B*5201 (.221-B*5201) in vitro. As shown in Figure 5B, the human CD8+ T cells and the CD8 T cells (mostly CD4+ T cells) reconstituted in the mice did not proliferate in response to.221-A*2402 or. 221-B*5201 cells. In addition, they did not proliferate in response to splenocytes of C57BL/6(H-2b) or Balb/c (H-2d) mice (data not shown). These results together indicate that the human CD8+ T cells could not recognize alloantigens in the mice.

Figure 5
Alloreactivity of human CD8+ T cells reconstituted in hNOK mice.

Discussion

It had remained unknown whether antigen-specific human T cell responses can be elicited in immunodeficient mice transplanted with only human CD34+ HSCs. In the present study, we analyzed the differentiation of the reconstituted human T cells and the function of the human CD8+ T cells stimulated by alloantigens in hNOK mice. Because human T cells express 4 cell-surface markers (CD27, CD28, CD45RA, and CCR7) and 3 cytolytic molecules (GraA, GraB, and Per) at different levels according to their stage of differentiation and maturation [22], [23], [25], the analysis of phenotype and effector molecule expression in the reconstituted human T cells is useful to clarify their differentiation status and effector function. We demonstrated that the CD27lowCD28CD45RA+/−CCR7 (late effector memory) and the CD27CD28CD45RA+/−CCR7 (effector) subsets did not exist among the human CD8+ T cells from the hNOK mice. In addition, the reconstituted human CD8+ T cells did not include the PerhighGraA+GraB+ (effector) cells. These results suggest that the reconstituted human CD8+ T cells did not have their effector function in vivo. On the other hand, the reconstituted human CD8+ T cells included the CD27+CD28+CD45RACCR7 (early effector memory) subsets in the hNOK mice, suggesting that the human CD8+ T cells could differentiate into memory T cells in the hNOK mice in response to some stimulation. Although early effector memory CD8+ T cells among the human adult CD8+ T cell population include PerlowGraA+GraB cells [25], the reconstituted human CD8+ T cells did not include the PerlowGraA+GraB ones. This finding suggests that some population of early effector memory CD8+ T cells in the mice were defective and could not express Per in the course of their differentiation. These results further suggest that the human CD8+ T cells did not have their effector function in the hNOK mice. On the other hand, the reconstituted human CD8+ T cells showed the ability to produce cytokines similar to that of human adult CD8+ T cells.

The linear differentiation model supports the idea that the naive T cells differentiate directly into effector cells during the acute phase of the response and that following contraction in the numbers of the effector cells at the end of the primary response, effector memory and central memory T cells become detectable [30]. However, the human CD8+ T cells reconstituted in the hNOK mice showed the lack of Per expression and PerlowGraA+GraB subset, implying that the cells could not differentiate into effector cells and subsequently differentiate into memory cells. The results of phenotypic analysis and effector molecule expression of the reconstituted human CD8+ T cells in the hNOK mice support the idea that the human CD8+ T cells asymmetrically divided into long-lived memory cells [30], [31].

A previous study demonstrated the presence of alloantigen-specific cytotoxic human T cell clones in hNOG mice [5]. However, the data from that study do not exactly reflect T cell responses in vivo; because alloantigen-specific human CD8+ T cell clones were established from the spleen cells of the mice cultured with allogeneic target cells in vitro. The frequency of the human alloreactive T cell repertoire was evaluated to reflect between 0.1% and 10% of the total T cell population, whereas that of T cells specific for foreign antigen is <1/100,000 [28], [29]. Since the reconstituted human CD8+ T cells did not respond to alloantigen in the hNOK mice, these reconstituted human CD8+ T cells may not have a foreign antigen-specific function in vivo. This result implies that the reconstituted human CD8+ T cells did not have the appropriate T cell receptor (TCR) repertoire against foreign antigens, because the human CD8+ T cells were educated by mouse MHC-peptide complexes in the thymus. CD8 co-receptors bind with a nonpolymorphic region within the α3 domain of class I MHC proteins, and their binding has species specificity [32][36]. Considering that human CD8 molecules fail to bind to murine MHC, the human CD8+ T cells in immunodeficient mice transplanted with only human CD34+ HSCs are not educated in the murine thymus.

There are several reports that antigen-specific responses are detectable in BLT mice infected with EBV or HIV [12], [14], [16]. Furthermore, the BLT mice produce high levels of human IgM and IgG antibodies and mediate strong immune responses in vivo, as demonstrated by skin xenograft rejection [13]. These results suggest that the reconstituted human T cells educated in the human thymus can have appropriate antigen-specific function in mice. A recent study demonstrated that the human CD8+ T cells reconstituted in HLA transgenic NOG mice transplanted with only human CD34+ HSCs expressed IFN-γ production and EBV-specific cytolytic activity in response to an EBV infection [37], [38], suggesting that the reconstituted human T cells educated by human HLA class I molecules on mouse thymus cells have appropriate effector function in the mice.

In the present study, we demonstrated impaired differentiation of human CD8+ T cells in the hNOK mice established with only human CD34+ T cells and lack of ability to induce the effector function. Previous studies of hNOG mice showed very weak immune responses to viral antigens [8], [9], [11]. Thus both hNOK and hNOG mice seems to have no or weak ability in HLA-restricted T cell responses although it is unclear whether some differences exist in human T cell function between 2 humanized mice. HLA transgenic immunodeficient mice are expected to be useful for the generation of a good mouse model having human immunity.

Materials and Methods

Establishment of humanized mice

The NOK mouse strain was established by backcrossing JAK3−/− mice with the NOD.Cg-Prkdcscid strain for 10 generations. The NOK mice were maintained under specific pathogen-free conditions in the Center for Animal Resources and Development. Animal experiments were conducted according to the Regulation for Animal Experiments in Kumamoto University (Approval ID, C22-168: Analysis of immune responses against viral diseases by using humanized and HLA transgenic mice). Human CB was purchased from Riken Cell Bank (Tsukuba, Japan). Human CD34+ cells were isolated from human CB by using a Direct CD34 Progenitor Cell Isolation Kit and an MS Column (Miltenyi Biotec, Gladbach, Germany). The usual purity of the human CD34+ cells was approximately 95%. The hNOK mice were generated by injecting the isolated human CD34+ cells (5×104 cells/mouse) into the liver of newborn NOK mice.

Blood samples

Human blood samples were taken from healthy adult individuals. Peripheral blood mononuclear cells (PBMC) were isolated from the blood by using Ficoll-Paque PLUS (GE Healthcare, Uppsala, Sweden).

Cell lines

721.221 cells are human B cell lines lacking HLA class I but not HLA class II [39]. 721.221 cells expressing HLA-A*2402 (.221-A*2402) and those expressing HLA-B*5201 (.221-B*5201) were generated by transfecting of HLA-A*2402 and HLA-B*5201 genes into 721.221 cells, respectively.

Flow cytometric analysis

Human leukocytes reconstituted in hNOK mice were stained with various combinations of monoclonal antibodies (mAbs): FITC-labeled anti-mouse CD45 (mCD45), PECy7-labeled human CD45 (hCD45), allophycocyanin-labeled anti-CD4, allophycocyanin, Cy7-labeled anti-CD4, AmCyan-labeled anti-CD8, Pacific blue-labeled anti-CD8, PE-labeled anti-CD19, FITC-labeled anti-Per, PE-labeled anti-GraA, Alexa647-labeled anti-GraB, PE-Cy7-labeled anti-CCR7, FITC-labeled anti-CD45RA, PE-labeled anti-CD28, allophycocyanin-Cy7-labeled anti-CD27, FITC-labeled IFN-γ and PE-Cy7-labeled TNF-α mAbs, all were purchased from BD Biosciences (San Diego, CA). ECD-labeled anti-CD3 mAb was obtained from Beckman Coulter (Fullerton, CA); and allophycocyanin-labeled IL-2 mAb, from e-bioscience (San Diego, CA). To analyze the phenotype of human T cells reconstituted in the hNOK mice, we first stained the human T cells with anti-CCR7 mAb for 30 min at room temperature, and subsequently with specific antibody against surface markers at 4°C for 30 min. The cells were washed twice with PBS containing 10% fetal calf serum (FCS; Sigma-Aldrich, St. Louis, MO). To analyze the intracellular expression of IFN-γ, Per, GraA, and GraB, we fixed cells with 4% paraformaldehyde PBS at 4°C for 20 min, and then made them permeable by incubating them at 4°C for 10 min in PBS containing 0.1% saponin (Sigma-Aldrich) and 20% FCS (permeabilizing buffer). The cells were then stained with anti-IFN-γ, anti-Per, anti-GraA, and anti-GraB mAbs at 4°C for 20 min. Finally, the stained cells were washed 3 times in the permeabilizing buffer at 4°C. The stained cells were analyzed by using a FACSCant II flow cytometer (BD Biosciences, San Jose, CA). All flow cytometric data were analyzed by using FlowJo software (Tree Star, Inc, Ashland, OR).

Cytokine production of human CD8+ T cells stimulated with PMA and ionomycin

The splenocytes of hNOK mice were cultured at a density of 1×106 cells in 96- well plates with phorbol 12-myristate 13-acetate (PMA) (10 ng/ml) and ionomycin (1 ng/ml). Two hours later, brefeldin A (10 ng/ml) was added to each well. After a further 4-hour incubation, the splenocytes were stained with Allophycocyanin-labeled anti-IL-2, FITC-labeled anti-IFN-γ, and PE-Cy7-labeled anti-TNF mAbs, and the stained cells were analyzed on the FACSCant II flow cytometer.

Assay for alloreactivity of human CD8+ T cells

PBMC (5×106/mouse) from a healthy donor with HLA types HLA-A*2402/A*2402, B*5201/B*5901, and DRB1*1502/DRB1*0405 were irradiated and then intraperitoneally injected into hNOK mice. At 4 weeks after the injection, PBMC and splenocytes of the hNOK mice were harvested and analyzed for their phenotype by using the FACSCant II. To investigate IFN-γ expression of human T cells against alloantigen, we cultured the splenocytes for 6 hours at a density of 1×106 cells in 96-well plates with the irradiated PBMC or irradiated self-CB. Then the cultured cells were stained with anti-CD3 mAb, anti-CD8 mAb, and anti-IFN-γ mAb. For proliferation assays, carboxyfluorescein diacetate N-succinimidyl ester (CFSE, Molecular Probes, Willow Creek Road Eugene, OR) for a final concentration of 0.5 µM was added to the cell suspension. After a 15-min incubation, the excess CFSE was removed by washing with 5% FCS/PBS; and then the cells were resuspended in RPMI1640 containing 10% FCS. The CFSE-labeled cells were cultured for 3 days with 721.221 cells expressing HLA-A*2402 or HLA-B*5201 and then were analyzed on the FACSCant II.

Statistical analysis

Results shown as bar graphs were expressed as the means ± S.E.M. One-way ANOVA followed by Dunnet's test was used for multiple comparisons. Differences were considered to be statistically significant when the p-value was less than 0.05.

Supporting Information

Figure S1

Phenotypic analysis of reconstituted human CD8+ T cells stimulated with alloantigen in hNOK mice hNOK mice were immunized for 31 days with irradiated human PBMC from a healthy donor with HLA-A*2402/A*2402, HLA-B*5201/B*5901, and HLA-DRB1*1502/DRB1*0405. Then the phenotype of human CD8+ T cells among PBMC from the hNOK mice was analyzed on 0, 7, and 31 days after the immunization. Splenocytes from the same mice were examined at day 31. (A) Representative results of 5-color flow cytometric analysis of CCR7CD45RACD27CD28 subsets in human CD8+ T cell population of PBMC and splenocytes are shown. (B) Representative results for Per, GraA, and GraB expression by the human CD8+ T cells among splenocytes from the hNOK mice are shown.

(1.97 MB TIF)

Acknowledgments

The authors thank Masumichi Saito for his discussion and Sachiko Sakai for her secretarial assistance.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This research was supported by grant-in-aid for scientific research from the Ministry of Health to YS (No. 08062169), by the grant to MT (No. 20390134) and that from the Global COE program “Global Education and Research Center Aiming at the control of AIDS”, launched as a project commissioned by the Ministry of Education, Science, Sports, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7:118–30. [PubMed]
2. Manz MG. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity. 2007;26:537–541. [PubMed]
3. Legrand N, Weijer K, Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol. 2006;176:2053–2058. [PubMed]
4. Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, et al. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model. Blood. 2003;102:873–880. [PubMed]
5. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice. Blood. 2005;106:1565–1573. [PubMed]
6. Matsumura T, Kametani Y, Ando K, Hirano Y, Katano I, et al. Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/γcnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp Hematol. 2003;31:789–797. [PubMed]
7. Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γcnull (NOG) mice (hu-HSC NOG mice). Int Immunol. 2009;21:843–858. [PubMed]
8. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304:104–107. [PubMed]
9. Yahata T, Ando K, Nakamura Y, Ueyama Y, Shimamura K, et al. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor γ null mice. J Immunol. 2002;169:204–209. [PubMed]
10. Marodon G, Desjardins D, Mercey L, Baillou C, Parent P, et al. High diversity of the immune repertoire in humanized NOD.SCID. γc−/− mice. Eur J Immunol. 2009;39:1–10. [PubMed]
11. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, et al. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis. 2008;198:673–682. [PubMed]
12. Melkus M W, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006;12:1316–1322. [PubMed]
13. Lan P, Tonomura N, Shimizu A, Wang S, Yang YG. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood. 2006;108:487–492. [PubMed]
14. Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, et al. Intrarectal transmission, systemic infection and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med. 2007;204:705–714. [PMC free article] [PubMed]
15. Wege AK, Melkus MW, Denton PW, Estes JD, Garcia JV. Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol. 2008;324:149–165. [PubMed]
16. Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol. 2009;83:7305–7321. [PMC free article] [PubMed]
17. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997;186:1407–18. [PMC free article] [PubMed]
18. Sobao Y, Tomiyama H, Nakamura S, Sekihara H, Tanaka K, et al. Visual demonstration of hepatitis C virus-specific memory CD8+ T-cell expansion in patients with acute hepatitis C. Hepatology. 2001;33:287–94. [PubMed]
19. Hamann D, Roos MT, van Lier RA. Faces and phases of human CD8 T-cell development. Immunol Today. 1999;20:177–80. [PubMed]
20. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708–12. [PubMed]
21. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 2001;410:106–11. [PubMed]
22. Tomiyama H, Matsuda T, Takiguchi M. Differentiation of human CD8+ T cells from a memory to memory/effector phenotype. J Immunol. 2002;168:5538–5550. [PubMed]
23. Tomiyama H, Takata H, Matsuda T, Takiguchi M. Phenotypic classification of human CD8+ T cells reflecting their function: an inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol. 2004;34:999–1010. [PubMed]
24. Barry M, Bleackley RC. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol. 2002;2:401–409. [PubMed]
25. Takata H, Takiguchi M. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol. 2006;177:4330–4340. [PubMed]
26. Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol. 2008;20:1189–1199. [PubMed]
27. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745–763. [PubMed]
28. Heeger PS. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant. 2003;3:525–533. [PubMed]
29. Whitelegg A, Barber LD. The structural basis of T-cell allorecognition. Tissue Antigens. 2004;63:101–108. [PubMed]
30. Bannard O, Kraman M, Fearon D. Pathways of memory CD8+ T-cell development. Eur J Immunol. 2009;39:2083–87. [PubMed]
31. Chang JT, Palanivel VR, Kinjyo I, Schambach F, Intlekofer AM, et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science. 2007;315:1687–91. [PubMed]
32. Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garrett TP, et al. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature. 1990;345:41–46. [PubMed]
33. Newberg MH, Ridge JP, Vining DR, Salter RD, Engelhard VH. Species specificity in the interaction of CD8 with the α3 domain of MHC class I molecules. J Immunol. 1992;149:136–142. [PubMed]
34. Moots RJ, Samberg NL, Pazmany L, Frelinger JA, McMichael AJ, et al. A cross-species functional interaction between the murine major histocompatibility complex class I α3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes. Eur J Immunol. 1992;22:1643–1646. [PubMed]
35. Teitell M, Holcombe H, Cheroutre H, Aldrich CJ, Stroynowski I, et al. The α3 domain of the Qa-2 molecule is defective for CD8 binding and cytotoxic T lymphocyte activation. J Exp Med. 1993;178:2139–2145. [PMC free article] [PubMed]
36. LaFace DM, Vestberg M, Yang Y, Srivastava R, DiSanto J, et al. Human CD8 transgene regulation of HLA recognition by murine T cells. J Exp Med. 1995;182:1315–1325. [PMC free article] [PubMed]
37. Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, et al. Priming of protectve T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med. 2009;206:1423–1434. [PMC free article] [PubMed]
38. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice. Proc Natl Acad Sci U S A. 2010 Early Edition 2010 Jul 6. [PubMed]
39. Shimizu Y, DeMars R. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J Immunol. 1989;142:3320–3328. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science